Alimta® (pemetrexed for injection) was the first chemotherapy drug in history that was approved by the U.S. Food and Drug Administration (FDA) for the purpose of treating malignant pleural mesothelioma patients who were not able to undergo surgery safely.
Developed in 2000 and approved by the FDA in 2004, Alimta® has consistently proven to be an effective treatment for mesothelioma patients. Numerous studies have indicated that Alimta® has the potential to extend patients’ survival times and improve their quality of life while dealing with the symptoms of mesothelioma.
At the law firm of Wallace & Graham, P.A., our primary focus is on representing people who have developed mesothelioma or another asbestos-related condition. In addition to seeking compensation for victims who were put at unnecessary risk due to asbestos exposure, we are committed to providing our clients with the information they need regarding mesothelioma treatment and other key issues.
The links below provide additional information about Alimta®, how it is used as part of a broader mesothelioma treatment regimen, and what patients can expect during the process:
Always consult with your doctor and/or oncologist before beginning any chemotherapy treatment regimen.
With offices in Salisbury, North Carolina, Wallace & Graham, P.A., handles mesothelioma claims. Call us at 1-888-698-9975 or contact us online for a free case evaluation. Our experienced and skilled asbestos lawyers will explain your rights and fight for you.